BC
Biomatics Capital Partners
Venture CapitalActiveBiomatics Capital Partners is a Seattle-based healthcare and life sciences venture firm.
24
Investments
6
Exits
$1.2B
AUM
25.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Biomatics Capital Partners.
Investment Thesis & Strategy
Biomatics Capital Partners invests in various stages of healthcare and life sciences companies, focusing on those based in the Seattle area.
Notable Exits
CompanyTypeYearValue / Acquirer
CureMatchAcquisition2023—
Vividion TherapeuticsAcquisition2021$1.9B
Silverback TherapeuticsIPO2020$192M
Adaptive BiotechnologiesIPO2019$1.4B
NantHealthIPO2016$1.4B
Cellular ResearchAcquisition2015—
Frequently Asked Questions
Biomatics Capital Partners focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Madrona Venture Group
Seattle, United States · 359 deals
Vulcan Capital
Seattle, United States · 194 deals
Voyager Capital
Seattle, United States · 152 deals
OVP Venture Partners
Seattle, United States · 115 deals
Washington Research Foundation
Seattle, United States · 54 deals
Second Avenue Partners
Seattle, United States · 43 deals